Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

FDA Approved Drugs: Changes to Approved Drugs

FDA Approved Drugs: Changes to Approved Drugs

Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...

Drug Regulation

Drug Regulation

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...

Drug Administration and Therapy Phases: Overview

Drug Administration and Therapy Phases: Overview

Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...

Drug Products: Biologics, Biosimilars and Interchangeables

Drug Products: Biologics, Biosimilars and Interchangeables

Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...

Prescription, Nonprescription and Orphan Drugs

Prescription, Nonprescription and Orphan Drugs

Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Pharmaceutical Approval Update.

P & T : a peer-reviewed journal for formulary management·2019

Same author

Pharmaceutical Approval Update.

P & T : a peer-reviewed journal for formulary management·2019

Same author

Pharmaceutical Approval Update.

P & T : a peer-reviewed journal for formulary management·2018

Same author

Pharmaceutical Approval Update.

P & T : a peer-reviewed journal for formulary management·2018

Same author

Pharmaceutical Approval Update.

P & T : a peer-reviewed journal for formulary management·2018

Same author

Pharmaceutical Approval Update.

P & T : a peer-reviewed journal for formulary management·2018

Search research articles

Related Experiment Video

Updated: Mar 15, 2026

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Published on: March 17, 2023

Pharmaceutical Approval Update.

P & T : a Peer-Reviewed Journal for Formulary Management

|September 16, 2016

Summary

This summary is machine-generated.

New drug approvals include Cabozantinib for advanced renal cell carcinoma, Bevespi Aerosphere for COPD, and Akovaz for hypotension during anesthesia. These treatments offer new options for patients with these serious conditions.

More Related Videos

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices

Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices

Published on: November 29, 2024

Related Experiment Videos

Last Updated: Mar 15, 2026

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Published on: March 17, 2023

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices

Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices

Published on: November 29, 2024

Area of Science:

Oncology
Pulmonology
Anesthesiology

Background:

Advanced renal cell carcinoma (RCC) presents significant treatment challenges.
Chronic obstructive pulmonary disease (COPD) requires effective long-term management strategies.
Hypotension during anesthesia can lead to serious complications.

Purpose of the Study:

To review the efficacy and safety of newly approved medications for specific medical conditions.
To provide an overview of therapeutic advancements in oncology, pulmonology, and anesthesiology.
To inform healthcare professionals about novel treatment options.

Main Methods:

Review of clinical trial data and regulatory submissions for new drug approvals.
Analysis of pharmacokinetic and pharmacodynamic profiles.
Evaluation of safety and tolerability data.

Main Results:

Cabozantinib (Cabometyx) demonstrated efficacy in advanced renal cell carcinoma.
Glycopyrrolate/formoterol fumarate (Bevespi Aerosphere) showed benefits in managing COPD symptoms.
Ephedrine sulfate (Akovaz) proved effective in treating hypotension during anesthesia.

Conclusions:

Cabozantinib, Bevespi Aerosphere, and Akovaz represent significant therapeutic advancements.
These new approvals offer valuable additions to the clinical armamentarium for treating RCC, COPD, and anesthesia-induced hypotension.
Further research and real-world data will continue to define the role of these agents.